![colonic mucosa with minimal crypt irregularity colonic mucosa with minimal crypt irregularity](https://www.pathologyoutlines.com/imgau/colonsolitaryrectalyulcerQiao01.jpg)
Weidner N, Cote RJ, Suster S, Weiss LM, eds. Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission. Guardiola J, Lobaton T, Rodriguez-Alonso L, et al. Fecal calprotectin identifies healing in ulcerative colitis. Level of fecal calprotectin correlates with endoscopic and histologic inflammation and identifies patients with mucosal healing in ulcerative colitis. Theede K, Holck S, Ibsen P, Ladelund S, Nordgaard-Lassen I, Nielsen AM. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Inflammatory diseases of the large intestine. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Diffuse duodenitis associated with ulcerative colitis. Valdez R, Appelman HD, Bronner MP, Greenson JK. Diagnostic difficulties in inflammatory bowel disease pathology. Therapy of ulcerative colitis: state of the art. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Immunopathogenesis of inflammatory bowel disease. What's new in inflammatory bowel disease in 2008?. Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. 8(4):351-7.īernstein CN, Fried M, Krabshuis JH, et al. Status of colitis-associated cancer in ulcerative colitis. Well-differentiated adenocarcinoma associated with ulcerative colitis.